Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models.

Vangala D, Ladigan S, Liffers ST, Noseir S, Maghnouj A, Gotze TM, Verdoodt B, Klein-Scory S, Godfrey L, Zowada MK, Huerta M, Edelstein DL, de Villarreal JM, Marques M, Kumbrink J, Jung A, Schiergens T, Werner J, Heinemann V, Stintzing S, Lindoerfer D, Mansmann U, Pohl M, Teschendorf C, Bernhardt C, Wolters H, Stern J, Usta S, Viebahn R, Admard J, Casadei N, Frohling S, Ball CR, Siveke JT, Glimm H, Tannapfel A, Schmiegel W, Hahn SA
Genome Med. 2021 Jul 16;13(1):116. doi: 10.1186/s13073-021-00926-7. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.